Clinical Trial Finder

Ask About Participating in This Study

OtherEnrolling

Study of SPI-1005 in people with CF ages 18 and older, protocol number Sound Pharma SPI-3005-501.2

The following information will be used to determine eligibility for this study. Fill out the form and click “Preview Message.” This will draft an email you can send directly to the Research Coordinator. Please note, this does not guarantee entry into this particular study.

* indicates required field

Personal Information

Your Full Name (required) Please enter your name

Your Email (required) Please enter a valid email address

Your Phone Number (required) Please enter a valid phone number

Study Location (required) Please choose a location

Additional Information:

Add more details about who you are and how you would like to be contacted (e.g. phone, text, email).

Required: I certify that I am at least 18 years old. I understand that I am authorizing Cff.org to send an e-mail from my personal e-mail account to a research coordinator. My email may contain sensitive information if I include it. I know that sending this e-mail is entirely optional and does not affect my ability to use other information on this website or to independently contact research sites separate from this website. I further understand that the Cystic Fibrosis Foundation does not accept responsibility for whether this e-mail reaches its intended recipient and what the intended recipient does with the information contained within this e-mail. The Cystic Fibrosis Foundation does not retain any information provided in this email in any form. Please check the box to continue

Preview Message

(this will open in your email program)

OtherEnrolling

Study of SPI-1005 in people with CF ages 18 and older, protocol number Sound Pharma SPI-3005-501.2

This study will test the safety and tolerability of SPI-1005, a drug intended to prevent and treat hearing loss caused by aminoglycosides.

Age:

18 Years and Older
Mutation(s):

No Mutation Requirement
FEV1% Predicted:

40% or greater
Number of Visits:

6
Length of Participation:

49 days

Clinical Studies 101

Questions to Ask When Considering a Specific Trial

Clinical trials that test potential drugs and therapies in people with cystic fibrosis are a major part of CF research. They take place at Cystic Fibrosis Foundation-accredited care centers all over the United States and enroll people with CF of all ages.
Patient Safety Is a Priority

Nothing is more important than patient safety in developing new treatments for cystic fibrosis. The U.S. government requires that all clinical trials are supervised for safety, and the Cystic Fibrosis Foundation adds additional measures to protect study volunteers.
How Do Clinical Trials Work

Each clinical trial has a study sponsor and a protocol. Potential drugs must move through four well-defined phases of testing in patients.

Get email updates about clinical trials that matter to you.

Email address Please enter a valid email address

Check the Drug Development Pipeline

We’re attacking CF from every angle. Learn about the status of CF drugs in development.

Learn More

Ask About Participating in This Study

Personal Information

* Study Location (required) Please choose a location

Additional Information:

Clinical Studies 101

Study Location (required) Please choose a location